Elevated Carbon Dioxide: Hypercapnia
Hypercapnia is the medical term for elevated carbon dioxide levels in the blood, defined as a PaCO₂ above the normal range of 4.6-6.1 kPa (34-46 mmHg). 1
Definition and Measurement
Hypercapnia occurs when the partial pressure of carbon dioxide (PaCO₂) in the arterial blood exceeds 6.1 kPa or 46 mmHg. This elevated level of carbon dioxide is a key indicator of type 2 respiratory failure, even if oxygen saturation remains within normal range. 1
Carbon dioxide in the blood is carried in three forms:
- 70-85% as bicarbonate
- 5-10% as dissolved carbon dioxide
- 10-20% bound to hemoglobin 1
Unlike oxygen, carbon dioxide carriage is not expressed as a saturation but rather by its partial pressure in the blood.
Causes of Hypercapnia
The four primary mechanisms that lead to hypercapnia are:
Alveolar hypoventilation or ineffective ventilation - By far the most common cause 1, 2
- COPD is the most frequent disease producing hypercapnia
- Rapid, shallow breathing increases dead space to tidal volume ratio
- Respiratory muscle weakness
Increased concentration of CO₂ in inspired gas 1, 2
- Iatrogenic cause - uncommon but should be excluded first
- Can occur with poorly configured breathing circuits
Increased carbon dioxide production 1, 2
- Usually only causes hypercapnia if minute ventilation is fixed
- Can occur with sepsis or increased work of breathing
Increased external dead space 1, 2
- Commonly seen in patients breathing through artificial circuits
Clinical Significance and Complications
Hypercapnia can lead to several physiological effects:
- Respiratory acidosis: When pH falls below 7.35 in the presence of elevated CO₂ 1
- Compensated respiratory acidosis: When the kidneys retain bicarbonate to buffer acidity, resulting in high PaCO₂ with high bicarbonate and normal pH 1
- Cerebral effects: Carbon dioxide is a vasodilator that can cause headache due to cranial vasodilation 1
- Neurological effects: High concentrations of CO₂ have hypnotic effects, potentially progressing from drowsiness to confusion to coma 1
- Cardiovascular effects: Patients may appear flushed with dilated peripheral veins and bounding pulse 1
Measurement Considerations
While arterial blood gas analysis is the gold standard for measuring PaCO₂, transcutaneous carbon dioxide monitoring (PtcCO₂) is increasingly used. However, it's important to note that PtcCO₂ tends to underestimate PaCO₂ levels, especially in cases of severe hypercapnia. 3
Management Principles
For patients at risk of hypercapnia:
- Oxygen therapy: Maintain oxygen saturation target of 88-92% to avoid worsening hypercapnia 1, 2
- Non-invasive ventilation: Consider when pH <7.35, PaCO₂ ≥6.5 kPa, and respiratory rate >23 breaths/min persist after optimal medical therapy 2
- Address underlying cause: Treatment should be directed at the primary cause of hypercapnia 4
Clinical Pitfalls
- Oxygen-induced hypercapnia: Between 20-50% of patients with AECOPD or obesity-hypoventilation syndrome are at risk of carbon dioxide retention if given excessively high oxygen concentrations 1
- Masking deterioration: Excessive oxygen therapy may delay recognition of clinical deterioration 1
- Severe acidosis: If respiratory rate exceeds 30 breaths/min with severe acidosis (pH <7.25), intubation should be considered 2
Remember that hypercapnia is not just a laboratory finding but a significant physiological disturbance that requires prompt recognition and appropriate management to prevent complications and improve outcomes.